Show simple item record

dc.contributor.authorTreviño, Ana
dc.contributor.authorSoriano, Vincent
dc.contributor.authorPoveda, Eva
dc.contributor.authorParra, Patricia
dc.contributor.authorCabezas, Teresa
dc.contributor.authorCaballero, Estrella
dc.contributor.authorRoc, Lourdes
dc.contributor.authorRodríguez, Carmen
dc.contributor.authorEiros Bouza, José María 
dc.contributor.authorLópez, Mariola
dc.contributor.authorMendoza, Carmen de
dc.date.accessioned2021-03-23T12:11:41Z
dc.date.available2021-03-23T12:11:41Z
dc.date.issued2014
dc.identifier.citationJournal of Antimicrobial Chemotherapy, 2014, vol. 69, n. 8, p. 2191-2194es
dc.identifier.issn0305-7453es
dc.identifier.urihttp://uvadoc.uva.es/handle/10324/45935
dc.descriptionProducción Científicaes
dc.description.abstractBackground:HIV-2 infection is characterized by low plasma viraemia and slower progression to AIDS in compari-son with HIV-1 infection. However, antiretroviral therapy in patients with HIV-2 is less effective and often fails toprovide optimal CD4 recovery.Methods:We examined viral tropism in persons with HIV-2 infection enrolled in the HIV-2 Spanish cohort. Viraltropism was estimated based on V3 sequences obtained from plasma RNA and/or proviral DNA.Results:From a total of 279 individuals with HIV-2 infection recorded in the Spanish national register, 58 V3sequences belonging to 42 individuals were evaluated. X4 viruses were recognized in 14 patients (33%).Patients with X4 viruses had lower median CD4+cell counts than patients with R5 viruses [130 (17 – 210) versus359 (180 – 470) cells/mm3;P¼0.007]. This was true even considering only the subset of 19 patients on antiretro-viral therapy [94 (16 – 147) versus 184 (43 – 368) cells/mm3;P¼0.041]. In multivariate analysis, significant differ-ences in CD4+cell counts between patients with X4 and R5 viruses remained after adjusting for age, gender,antiretroviral therapy and viral load.Conclusions:The presence of X4-tropic viruses in HIV-2 infection is associated with low CD4+cell counts, regard-less of antiretroviral treatment. Along with CD4+cell counts, viral tropism testing may assist decisions aboutwhen to initiate antiretroviral therapy in HIV-2-infected individuals.es
dc.format.mimetypeapplication/pdfes
dc.language.isoenges
dc.publisherOxford University Presses
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.classificationAntagonistases
dc.subject.classificationCarga provirales
dc.subject.classificationMaraviroces
dc.titleHIV-2 viral tropism influences CD4+ T cell count regardless of viral loades
dc.typeinfo:eu-repo/semantics/articlees
dc.rights.holder© Oxford University Presses
dc.identifier.doi10.1093/jac/dku119es
dc.relation.publisherversionhttps://academic.oup.com/jac/article/69/8/2191/2911286es
dc.identifier.publicationfirstpage2191es
dc.identifier.publicationissue8es
dc.identifier.publicationlastpage2194es
dc.identifier.publicationtitleJournal of Antimicrobial Chemotherapyes
dc.identifier.publicationvolume69es
dc.peerreviewedSIes
dc.description.projectFundación Investigación y Educación en Sida. (RIS, ISCIII-RETICRD/12/0017/0031)es
dc.description.projectFondo de Investigación Sanitaria (FIS, PI10/00520)es
dc.description.projectMinisterio de Salud Consumo y Bienestar Social (EC10/277)es
dc.description.projectMinisterio de Ciencia e Innovación (MICINN, SAF2010/22232)es
dc.description.projectEl proyecto Europeo CHAIN (FP7-223131)es
dc.identifier.essn1460-2091es
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones
dc.subject.unesco32 Ciencias Médicases


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record